Table 1.

Associations for rs10936599 at 3q26.2, rs907611 at 11p15.5, rs6104690 at 20p12.2 and rs4510656 at 6p22.3 with bladder cancer risk

SNP	Cytoband	Alleles	Minor allele	MAF	Cases	Controls	Group	ORadj	(95% CI)		Ptrend
rs10936599	3q26.2	T/C	T	0.24	2415	5751	NCI-GWAS2	0.81	0.73	0.89
				0.24	3517	5107	NCI-GWAS1	0.88	0.81	0.94
				0.24	969	957	TXBCS-GWAS	0.84	0.72	0.98
				0.25	790	1293	TXBCS-TaqMan	0.90	0.77	1.05
					7691	13 108	Combined	0.85	0.81	0.90	4.53 × 10−9
rs907611	11p15.5	G/A	A	0.31	2379	5720	NCI-GWAS2	1.25	1.14	1.36
				0.33	2757	4314	NCI-GWAS1	1.12	1.04	1.2
				0.32	968	955	TXBCS-GWAS	1.20	1.04	1.39
				0.31	797	1291	TXBCS-TaqMan	0.97	0.84	1.12
					6901	12 280	Combined	1.15	1.09	1.21	4.11 × 10−8
rs6104690	20p12.2	G/A	G	0.44	2409	5747	NCI-GWAS2	0.89	0.82	0.96
				0.44	3510	5097	NCI-GWAS1	0.89	0.84	0.95
				0.45	969	957	TXBCS-GWAS	0.91	0.79	1.04
				0.46	790	1287	TXBCS-TaqMan	0.89	0.78	1.02
					7678	13 088	Combined	0.89	0.85	0.93	7.13 × 10−7
rs4510656	6p22.3	C/A	A	0.45	2416	5747	NCI-GWAS2	0.87	0.8	0.95
				0.43	3515	5106	NCI-GWAS1	0.91	0.85	0.97
				0.45	968	957	TXBCS-GWAS	0.88	0.77	1.01
				0.46	798	1300	TXBCS-TaqMan	0.90	0.79	1.03
					7697	13 110	Combined	0.89	0.85	0.93	6.98 × 10−7

OR adjusted for age, study group, smoking status and gender. Fixed-effects meta-analysis by stage was used to calculate the combined OR, 95% CI and P-trend.